StockWatch
·
Pharmaceuticals
Quarterly Result22 May 2026, 07:01 pm

Syncom Formulations: FY26 Revenue ₹486.57 Mn

AI Summary

Syncom Formulations India Ltd has released its audited financial results for the year ended March 31, 2026. The company reported revenue from operations of ₹486.57 million and a profit of ₹76.01 million for the year. The results were approved by the Audit Committee and Board of Directors in a meeting held on May 22, 2026. The auditors' report is unmodified, and the company is in the process of filing the results in XBRL format and publishing them in newspapers.

Key Highlights

  • Syncom Formulations reports revenue from operations of ₹486.57 million for FY26.
  • The company's profit for the period stood at ₹76.01 million.
  • Auditors' report accompanying the financial results is unmodified.
  • Board approved standalone and consolidated audited financial results on May 22, 2026.
  • Company is filing financial results in XBRL format and publishing in newspapers.